Questioning the benefit–harm balance of these drugs in dementia, a meta-analysis showed that discontinuation of cholinesterase inhibitors and memantine resulted in a worse cognitive, neuropsychiatric and functional status [39]. This evidence concerns the gene BCHE and dementia.